Genotype-guided pharmacotherapy for patient care: Status and perspective in Korea
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Presentation
- By: SHIN, Jae-Gook (Inje University College of Medicine Busan Paik Hospital, Pharmacology / Clinical Pharmacology, Busan, Korea, Republic Of)
- Co-author(s): Jae-Gook Shin
Pharmacogenomics (PGx) biomarkers are considered to be good predictors of individual drug responses for the personalized pharmacotherapy in the given individual patient. Although the genetic tests for the personalized pharmacotherapy are not routinely prescribed in the clinical practice, several pharmacogenomics biomarkers are already.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.